DaVita Inc.

NYSE:DVA Stock Report

Market Cap: US$10.2b

DaVita Past Earnings Performance

Past criteria checks 1/6

DaVita's earnings have been declining at an average annual rate of -1.2%, while the Healthcare industry saw earnings growing at 2.5% annually. Revenues have been growing at an average rate of 3.4% per year. DaVita's return on equity is 91%, and it has net margins of 5.3%.

Key information

-1.19%

Earnings growth rate

7.40%

EPS growth rate

Healthcare Industry Growth8.50%
Revenue growth rate3.37%
Return on equity90.96%
Net Margin5.29%
Last Earnings Update31 Dec 2025

Recent past performance updates

Recent updates

Even With A 30% Surge, Cautious Investors Are Not Rewarding DaVita Inc.'s (NYSE:DVA) Performance Completely

Feb 06
Even With A 30% Surge, Cautious Investors Are Not Rewarding DaVita Inc.'s (NYSE:DVA) Performance Completely

DaVita: Some Success Is Possible, But Volatility Is Still Heavy

Feb 03

Investors Aren't Entirely Convinced By DaVita Inc.'s (NYSE:DVA) Earnings

Aug 05
Investors Aren't Entirely Convinced By DaVita Inc.'s (NYSE:DVA) Earnings

Slowing Rates Of Return At DaVita (NYSE:DVA) Leave Little Room For Excitement

Jul 16
Slowing Rates Of Return At DaVita (NYSE:DVA) Leave Little Room For Excitement

We Ran A Stock Scan For Earnings Growth And DaVita (NYSE:DVA) Passed With Ease

Jun 28
We Ran A Stock Scan For Earnings Growth And DaVita (NYSE:DVA) Passed With Ease

An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 49% Undervalued

May 27
An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 49% Undervalued

DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

May 12
DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

DaVita Inc.'s (NYSE:DVA) Prospects Need A Boost To Lift Shares

Apr 14
DaVita Inc.'s (NYSE:DVA) Prospects Need A Boost To Lift Shares

Returns On Capital At DaVita (NYSE:DVA) Have Stalled

Apr 02
Returns On Capital At DaVita (NYSE:DVA) Have Stalled

We Ran A Stock Scan For Earnings Growth And DaVita (NYSE:DVA) Passed With Ease

Mar 20
We Ran A Stock Scan For Earnings Growth And DaVita (NYSE:DVA) Passed With Ease

The DaVita Dilemma: Flat Patient Enrollment And Lawsuits, Yet An Improvement In Net Income Margin

Mar 17

Is Now An Opportune Moment To Examine DaVita Inc. (NYSE:DVA)?

Mar 07
Is Now An Opportune Moment To Examine DaVita Inc. (NYSE:DVA)?

DaVita: Momentum Could Fade Given High Valuation

Feb 05

DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

Nov 14
User avatar

Critical Investments And Policy Changes Propel Healthcare Innovator Towards Brighter Financial Horizons

DaVita's investments in technology and workforce initiatives aim to enhance revenue operations and patient care, contributing to future growth and profitability.

DaVita Stock Is A Hold As It Expands In Latin America

Mar 18

DaVita: Assessing After The Rally

Dec 29

Revenue & Expenses Breakdown

How DaVita makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:DVA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2513,6437221,6490
30 Sep 2513,3187721,5920
30 Jun 2513,1618361,5950
31 Mar 2512,9698601,5500
31 Dec 2412,8169361,5380
30 Sep 2412,6678281,5690
30 Jun 2412,5248601,5090
31 Mar 2412,3388161,5050
31 Dec 2312,1406921,4740
30 Sep 2311,9115961,4080
30 Jun 2311,7394541,4410
31 Mar 2311,6655001,3920
31 Dec 2211,6105471,3550
30 Sep 2211,6376801,2980
30 Jun 2211,6278341,2260
31 Mar 2211,6169031,2090
31 Dec 2111,6199781,1950
30 Sep 2111,5809841,1770
30 Jun 2111,5668831,2470
31 Mar 2111,5297911,2300
31 Dec 2011,5517831,2480
30 Sep 2011,5448321,1860
30 Jun 2011,5248241,1220
31 Mar 2011,4878161,1160
31 Dec 1911,3887051,1030
30 Sep 1911,3116231,0930
30 Jun 1911,2535481,1310
31 Mar 1911,3005511,1200
31 Dec 1811,4126161,1350
30 Sep 1811,3786171,1200
30 Jun 1811,2996981,0570
31 Mar 1811,1106521,0560
31 Dec 1710,8849091,0520
30 Sep 177,7731,0657070
30 Jun 178,7321,4808250
31 Mar 179,7471,3829490
31 Dec 1610,6961,0381,0570
30 Sep 1614,5507161,5730
30 Jun 1614,3473611,5360
31 Mar 1614,0654781,4970
31 Dec 159,9733231,0310
30 Sep 1513,5654841,3990
30 Jun 1513,2904521,3690
31 Mar 1513,0274291,3190

Quality Earnings: DVA has high quality earnings.

Growing Profit Margin: DVA's current net profit margins (5.3%) are lower than last year (7.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: DVA's earnings have declined by 1.2% per year over the past 5 years.

Accelerating Growth: DVA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: DVA had negative earnings growth (-22.9%) over the past year, making it difficult to compare to the Healthcare industry average (15.9%).

Return on Equity

High ROE: Whilst DVA's Return on Equity (90.96%) is outstanding, this metric is skewed due to their high level of debt.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/04 23:01
End of Day Share Price 2026/03/04 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DaVita Inc. is covered by 31 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew GillmorBaird
Andrew MokBarclays
Steven ValiquetteBarclays